BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4721444)

  • 1. The Tay-Sachs disease fibroblast model: failure to respond to exogenous hexosaminidase A.
    Schneck L; Amsterdam D; Brooks SE; Rosenthal AL; Volk BW
    Pediatrics; 1973 Aug; 52(2):221-6. PubMed ID: 4721444
    [No Abstract]   [Full Text] [Related]  

  • 2. Gm2-gangliosidosis: studies in cultured fibroblasts.
    Kolodny EH; Milunsky A; Sheng GS
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):130-5. PubMed ID: 4611525
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous injection of purified hexosaminidase A into a patient with Tay-Sachs disease.
    Johnson WG; Desnick RJ; Long DM; Sharp HL; Krivit W; Brady B; Brady RO
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):120-4. PubMed ID: 4611523
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine.
    Li YT; Mazzotta MY; Wan CC; Orth R; Li SC
    J Biol Chem; 1973 Nov; 248(21):7512-5. PubMed ID: 4745777
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in Tay-Sachs and Sandhoff's diseases. Immunologic and structural properties of hexosaminidase A and hexosaminidase B.
    Beutler E; Srivastava SK
    Isr J Med Sci; 1973; 9(9):1335-7. PubMed ID: 4798071
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
    Tallman JF; Johnson WG; Brady RO
    J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tay-Sachs disease: prospects for therapeutic intervention.
    Desnick RJ; Goldberg JD
    Prog Clin Biol Res; 1977; 18():129-41. PubMed ID: 601073
    [No Abstract]   [Full Text] [Related]  

  • 8. Tay-Sachs disease with altered beta-hexosaminidase B: a new variant?
    Momoi T; Sudo M; Tanioka K; Nakao Y
    Pediatr Res; 1978 Feb; 12(2):77-81. PubMed ID: 25409
    [No Abstract]   [Full Text] [Related]  

  • 9. Gangliosidosis with total hexosaminidase deficiency: clinical, biochemical and ultrastructural studies and comparison with conventional cases of Tay-Sachs disease.
    Fontaine G; Résibois A; Tondeur M; Jonniaux G; Farriaux JP; Voet W; Maillard E; Loeb H
    Acta Neuropathol; 1973 Jan; 23(2):118-32. PubMed ID: 4349527
    [No Abstract]   [Full Text] [Related]  

  • 10. Disorders of ganglioside metabolism.
    Brady RO; Kolodny EH
    Prog Med Genet; 1972; 8():225-41. PubMed ID: 4336471
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tay-Sachs disease].
    Okada S
    Nihon Rinsho; 1973 Aug; 31(8):2463-8. PubMed ID: 4588056
    [No Abstract]   [Full Text] [Related]  

  • 12. Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Birth Defects Orig Artic Ser; 1975; 11(3):232-5. PubMed ID: 812568
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the substrate specificity of hexosaminidase A and B from liver.
    Wenger DA; Okada S; O'Brien JS
    Arch Biochem Biophys; 1972 Nov; 153(1):116-29. PubMed ID: 4346630
    [No Abstract]   [Full Text] [Related]  

  • 14. Human hexosaminidase isozymes: chromatographic separation as an aid to heterozygote identification.
    Nakagawa S; Kumin S; Nitowsky HM
    Clin Chim Acta; 1977 Mar; 75(2):181-91. PubMed ID: 851488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs.
    Sandhoff K; Andreae U; Jatzkewitz H
    Pathol Eur; 1968; 3(2):278-85. PubMed ID: 5688464
    [No Abstract]   [Full Text] [Related]  

  • 16. Tay-Sachs disease: ultrastructural studies on cultured fibroblasts.
    Wyatt PR; Cox DM; Hoogstraten J
    Pediatr Res; 1978 Apr; 12(4 Pt 1):310-3. PubMed ID: 652414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L
    J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid and simple microfractionation method for the analysis of hexosaminidase A and B activities in small numbers of cultured (amniotic fluid) cells.
    D'Azzo A; Hoogeveen A; De Wit-Verbeek HA
    Clin Chim Acta; 1978 Aug; 88(1):1-7. PubMed ID: 679481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the beta-bexosyminidase separation by electrophoresis in homozygote and heterozygote Tay-Sachs cultured fibroblasts.
    Liebaers I; Vamos E; Mandelbaum IM
    Acta Clin Belg; 1974; 29(2):94-7. PubMed ID: 4839716
    [No Abstract]   [Full Text] [Related]  

  • 20. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
    Yuasa T; Fukuma M; Takashima S; Takaki R
    Arch Pathol Lab Med; 1980 Jun; 104(6):321-7. PubMed ID: 6246846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.